On Tuesday, the U.S. Supreme Court heard arguments in a case that could restrict access to mifepristone, one of two drugs used in medication abortions, nationwide.
The argument comes at a time where access to abortion across the country is under attack. Abortion is totally banned or partially banned in 21 states. At the same time, medication abortion accounts for 63% of abortions; an increase from 53% in 2020, in part due to changes that the Food and Drug Administration (FDA) made in 2016 and 2021 that removed some barriers to access mifepristone.
